Emerging Omics Small biotechnology player focused on the Omics marketplace with in-house DNA array synthesis and specialized readouts, presenting an opportunity to upsell instrumentation, consumables, and service contracts to early-stage customers expanding their genomics capabilities.

Instruments & Services Product suite includes B3 Synthesizer and on-chip DNA array synthesis with multiple chip formats, plus ready-made arrays and readout options (fluorescence or electrochemical). Sales potential lies in bundling hardware with custom services like gene/microRNA expression profiling and aptamer/siRNA discovery.

Flexible Readouts Dual-readout capability (fluorescence and electrochemical) via ElectraSense suggests a cross-sell path to customers seeking alternative detection methods, capturing stakeholders across core labs, diagnostics, and translational research teams.

Phase & Scale Current revenue under one million with 2–10 employees indicates a small but agile operation ripe for strategic partnerships, channel deals, and pilot programs to accelerate customer acquisition and expand footprint in mid-to-late-stage Omics projects.

Competitive Positioning Compared to larger competitors, CustomArray offers rapid on-chip synthesis and flexible array formats with bespoke services; outreach can target customers of bigger suppliers seeking specialized, faster, or cost-effective alternative workflows and contracted service bundles.